Table.Briefings

Feature

Trilogue agreement on phase-out of free carbon allowances

Emissions trading for buildings and transport is coming

At just before 2 a.m. on Sunday, the deal in the jumbo trilogue on the reform of emissions trading was reached: The ambition level will rise, the carbon price for buildings and road transport will be introduced, and the free emissions allowances for the industry will end in 2034. This means that the essential part of the Fit for 55 package is ready.

By Lukas Knigge

Kerry_Brown

'Europe perceives China as a counterpart'

The renowned British sinologist Kerry Brown is concerned about an increasingly hostile perception in Western countries of China. Because in return, rejection of the West also intensifies there. A vicious circle: China's population now has a negative image of the USA and the EU. Ning Wang spoke with Brown.

By Ning Wang

How Europe intends to respond to the IRA

In the dispute between the EU and the USA over the Inflation Reduction Act a compromise is in sight. Nevertheless, the member states and the EU Commission fear a creeping exodus of European industry. At the EU summit, they instructed the EU Commission to develop countermeasures. Many of these measures are already on the horizon.

By Till Hoppe

Fair Share levy: Germany sees no need

Will the Commission make a proposal in 2023 that Netflix, Amazon, and Co. should help finance broadband expansion in the future? The European Telecommunications Network Operator’s Association ETNO has been beating the drum for "Fair Share" for years. But the German government thinks little of the Commission's ideas so far.

By Falk Steiner

Kaili case: EP suspends eleven NGO employees

Parliament President Roberta Metsola makes the reform of transparency rules a top priority. She had received an invitation to the World Cup from Qatar herself, Metsola explained on the sidelines of the EU summit.

By Markus Grabitz

Emission reduction pathways in the ETS

Jumbo trilogue: the three sticking points of the EU climate package 

European climate policy is in for some decisive days: This weekend, the most important parts of the EU’s Fit-for-55 climate package are expected to be finalized in the trilogue. The negotiations will focus primarily on European emissions trading. Associated with this are talks on the Social Climate Fund and the Carbon Border Adjustment Mechanism (CBAM) – as these are big topics in themselves, some call it the jumbo trilogue.

By Lukas Knigge

epa07592272 People work in Hengrui Medicine research laboratory in Lianyungang, Jiangsu Province, China, 21 May 2019.
Town of Lianyungang hosts two large scale but essentially different medical and pharmaceutics companies. 
Differences between Western medicine and Traditional Chinese medicine (TCM) are various such as approaches to the patient exams and medical prescriptions.  The Western approach clearly divides the health from the disease, yet TCM approach considers health as a balanced state vs disease as an unbalanced state.
Hengrui Medicine company specializes in anti-tumor research and it is the largest producer of cancer related drugs in China. It was 64th on Forbes 2018 list of world's most innovative companies. Companies most famous drug is Docetaxel witch can be used for prostate and adaptive breast cancer, and it's approved by FDA of US. Another medicine is called Cyclophosphamide with great effects on lymphoma leukemia and multiple melanoma. Company clams this drug take about half of the US market share.
Kanion Pharmaceutical is has the largest intelligent line of traditional Chinese herbal medicine extraction in China. Company has the largest number of innovation patents in Chinese medicine industry. TCM or Traditional Chinese Medicine is one of the oldest healing systems on the planet. Includes herbal medicine, dietary therapy, acupuncture, massage and exercise.  It stimulates the body's own healing mechanism and takes into account all aspects of patient's life, rather then just several obvious signs of symptoms.
EPA-EFE/ALEKSANDAR PLAVEVSKI  EPA-EFE/Aleksandar Plavevski

Dependence also for ibuprofen and paracetamol

Many pharmaceuticals and their active ingredients, like ibuprofen or paracetamol, nowadays come from China or India. This makes Germany dependent in this area as well – and is a problem if supply chains become disrupted.

By Redaktion Table